Skip to main content
ConductScienceScienceDex

Thomas Delong

From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.

FY2026 NIH rank #6,091
Unclaimed recordClaim profile
  • Rising Star
  • Program Leader
  • R01 Holder
  • Translational
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 9753886Search this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pharmacology

NIH Funding · FY2026

Linked Award Amount
$3M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#6,091
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Thomas Delong. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Thomas Delong as a PI. Multi-PI records show the full award amount for context.

  • 4U01DK143495-02U01Contact PI
    The Role of Granular Acidification in the Pathogenesis of Type 1 Diabetes
    University of Colorado
    $2M
    award amount
  • 5R01DK119529-09R01Contact PI
    Characterize the Landscape and Origin of Hybrid Peptides in Beta Cells
    University of Colorado
    $529.6K
    award amount
  • 1R21AI196871-01R21Contact PI
    Species-Specific Regulation of Autoantigen Processing: A Humanized Mouse Model of Cathepsin D in Type 1 Diabetes
    University of Colorado · Pharmacology (NIH department code)
    $429K
    award amount

Award organization

Organizations that administered FY2026 awards listing Thomas Delong as a PI.

FY2026 award administered by University of Colorado (CO).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Colorado
  2. 2024
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding
  4. 2025
    $2M Cumulative Funding
  5. 2025
    Entered Top 50% Nationally
    Ranked #8039
  6. 2025
    R01 Grant Holder
  7. 2025
    Program/Center Grant Leader
  8. 2026
    $5M Cumulative Funding

Explore further

Find collaborators for Thomas Delong

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →